Journal article · 2013 · Open access

Four-dimensional microglia response to anti-Aβ treatment in APP/PS1xCX3CR1/GFP mice

Mónica García-Alloza, Laura A. Borrelli, Diana H. Thyssen, Suzanne E. Hickman, Joseph B. El Khoury, Brian J. Bacskai

IntraVital, 2(2), e25693 · Published 1 April 2013 · DOI 10.4161/intv.25693

Open full textCite this paper

In brief

“Four-dimensional microglia response to anti-Aβ treatment in APP/PS1xCX3CR1/GFP mice” is a 2013 journal article by Mónica García-Alloza and 5 co-authors, published in IntraVital. OpenAlex counts 10 citations as of 18 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at IntraVital.

Citations
10
Most cited in
2018 (2)
Field-weighted impact
0.31
References
54
Authors
6

Abstract

Senile plaques, mainly composed of amyloid-β (Aβ), are a major hallmark of Alzheimer disease (AD), and immunotherapy is a leading therapeutic approach for Aβ clearance. Although the ultimate mechanisms for Aβ clearance are not well known, characteristic microglia clusters are observed in the surround of senile plaques, and are implicated both in the elimination of Aβ as well as the deleterious inflammatory effects observed in AD patients after active immunization. Therefore, analyzing the direct effect of immunotherapy on microglia, using longitudinal in vivo multiphoton microscopy can provide important information regarding the role of microglia in immunotherapy. While microglia were observed to surround senile plaques, topical anti-Aβ antibody administration, which led to a reduction in plaque size, directed microglia toward senile plaques, and the overall size of microglia and number of processes were increased. In some cases, we observed clusters of microglia in areas of the brain that did not have detectable amyloid aggregates, but this did not predict the deposition of new plaques in the area within a week of imaging, indicating that microglia react to but do not precipitate amyloid aggregation. The long-term presence of large microglial clusters in the surrounding area of senile plaques suggests that microglia cannot effectively remove Aβ unless anti-Aβ antibody is administered. All together, these data suggest that although there is a role for microglia in Aβ clearance, it requires an intervention like immunotherapy to be effective.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

García-Alloza, M., Borrelli, L. A., Thyssen, D. H., Hickman, S. E., El Khoury, J. B., & Bacskai, B. J. (2013). Four-dimensional microglia response to anti-Aβ treatment in APP/PS1xCX3CR1/GFP mice. IntraVital, 2(2), e25693. https://doi.org/10.4161/intv.25693

MLA 9

García-Alloza, Mónica, et al. “Four-dimensional microglia response to anti-Aβ treatment in APP/PS1xCX3CR1/GFP mice.” IntraVital, vol. 2, no. 2, 2013, p. e25693. https://doi.org/10.4161/intv.25693.

Chicago

García-Alloza, Mónica, Laura A. Borrelli, Diana H. Thyssen, Suzanne E. Hickman, Joseph B. El Khoury, and Brian J. Bacskai. 2013. “Four-dimensional microglia response to anti-Aβ treatment in APP/PS1xCX3CR1/GFP mice.” IntraVital 2 (2): e25693. https://doi.org/10.4161/intv.25693.

Harvard

García-Alloza, M. et al. (2013) ‘Four-dimensional microglia response to anti-Aβ treatment in APP/PS1xCX3CR1/GFP mice’, IntraVital, 2(2), p. e25693. doi:10.4161/intv.25693.

IEEE

M. García-Alloza, L. A. Borrelli, D. H. Thyssen, S. E. Hickman, J. B. El Khoury, and B. J. Bacskai, “Four-dimensional microglia response to anti-Aβ treatment in APP/PS1xCX3CR1/GFP mice,” IntraVital, vol. 2, no. 2, p. e25693, 2013, doi: 10.4161/intv.25693.

BibTeX

@article{garciaalloza2013four,
  title     = {{Four-dimensional microglia response to anti-Aβ treatment in APP/PS1xCX3CR1/GFP mice}},
  author    = {García-Alloza, Mónica and Borrelli, Laura A. and Thyssen, Diana H. and Hickman, Suzanne E. and El Khoury, Joseph B. and Bacskai, Brian J.},
  journal   = {IntraVital},
  year      = {2013},
  volume    = {2},
  number    = {2},
  pages     = {e25693},
  doi       = {10.4161/intv.25693},
  url       = {https://doi.org/10.4161/intv.25693}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201411
201511
201822
202111
202222
202311
202411
202511

Its field-weighted citation impact is 0.31: it has been cited 0.31 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms

  • microglia
  • amyloid-beta
  • Alzheimer's disease
  • anti-amyloid immunotherapy
  • amyloid plaques
  • APP/PS1 mice
  • CX3CR1
  • amyloid-beta clearance

Work with this paper

Most-cited papers in Neuroscience

All highly cited Neuroscience papers

Questions about this paper

How do I cite this paper in APA style?

García-Alloza, M., Borrelli, L. A., Thyssen, D. H., Hickman, S. E., El Khoury, J. B., & Bacskai, B. J. (2013). Four-dimensional microglia response to anti-Aβ treatment in APP/PS1xCX3CR1/GFP mice. IntraVital, 2(2), e25693. https://doi.org/10.4161/intv.25693

How many times has this paper been cited?

10 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at IntraVital: sign in and open the full text from this page.

Who wrote this paper?

Mónica García-Alloza, Laura A. Borrelli, Diana H. Thyssen, Suzanne E. Hickman, Joseph B. El Khoury, Brian J. Bacskai.

What is the DOI of this paper?

10.4161/intv.25693, permanently at https://doi.org/10.4161/intv.25693. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.